Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 11, 2013 - Issue 4
Submit an article Journal homepage
71
Views
1
CrossRef citations to date
0
Altmetric
Theme: Stroke - Review

Prevention and treatment of neurovascular in-stent stenoses: review of the concepts

Zsolt Vajda Health Center, University of Kaposvár, Kaposvár, Guba Sándor St 40, Hungary; Klinik für Neuroradiologie, Neurozentrum, Klinikum Stuttgart, Germany; Health Center, University of Kaposvár, Kaposvár, Guba Sándor St 40, Hungary; Klinik für Neuroradiologie, Neurozentrum, Klinikum Stuttgart, Germany
,
Thomas Güthe Klinik für Neuroradiologie, Neurozentrum, Klinikum Stuttgart, Germany; Klinik für Neuroradiologie, Neurozentrum, Klinikum Stuttgart, Germany
,
Marta Aguilar-Perez Klinik für Neuroradiologie, Neurozentrum, Klinikum Stuttgart, Germany; Klinik für Neuroradiologie, Neurozentrum, Klinikum Stuttgart, Germany
,
Wiebke Kurre Klinik für Neuroradiologie, Neurozentrum, Klinikum Stuttgart, Germany; Klinik für Neuroradiologie, Neurozentrum, Klinikum Stuttgart, Germany
,
Hansjörg Bäzner Neurologische Klinik, Neurozentrum, Bürgerhospital, Klinikum Stuttgart, Germany; Neurologische Klinik, Neurozentrum, Bürgerhospital, Klinikum Stuttgart, Germany
&
Hans Henkes Klinik für Neuroradiologie, Neurozentrum, Klinikum Stuttgart, Germany; Medizinische Fakultät der Universität Duisburg-Essen, North Rhine-Westphalia, Germany. [email protected]; Medizinische Fakultät der Universität Duisburg-Essen, North Rhine-Westphalia, Germany. [email protected]
Pages 463-468 | Published online: 10 Jan 2014

References

  • Schwartz RS, Holmes DR Jr, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J. Am. Coll. Cardiol. 20(5), 1284–1293 (1992).
  • Apisarnthanarax S, Chougule P. Intravascular brachytherapy: a review of the current vascular biology. Am. J. Clin. Oncol. 26(3), e13–e21 (2003).
  • Vajda Z, Schmid E, Güthe T et al. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent. Neurosurgery 70(1), 91–101; discussion 101 (2012).
  • Zaidat OO, Klucznik R, Alexander MJ et al.; NIH Multi-center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 70(17), 1518–1524 (2008).
  • Jiang WJ, Yu W, Du B, Gao F, Cui LY. Outcome of patients with =70% symptomatic intracranial stenosis after Wingspan stenting. Stroke 42(7), 1971–1975 (2011).
  • Fiorella DJ, Turk AS, Levy EI et al. U.S. Wingspan Registry: 12-month follow-up results. Stroke 42(7), 1976–1981 (2011).
  • Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 61(2), 236–42; discussion 242 (2007).
  • Chimowitz MI, Lynn MJ, Derdeyn CP et al.; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 365(11), 993–1003 (2011).
  • Bose A, Hartmann M, Henkes H et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 38(5), 1531–1537 (2007).
  • Fiorella D, Levy EI, Turk AS et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 38(3), 881–887 (2007).
  • Chimowitz MI, Lynn MJ, Derdeyn CP et al.; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 365(11), 993–1003 (2011).
  • Turk AS, Levy EI, Albuquerque FC et al. Influence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am. J. Neuroradiol. 29(1), 23–27 (2008).
  • Levy EI, Turk AS, Albuquerque FC et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 61(3), 644–650; discussion 650 (2007).
  • Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104(5), 600–605 (2001).
  • Kereiakes DJ, Cox DA, Hermiller JB et al.; Guidant Multi-Link Vision Stent Registry Investigators. Usefulness of a cobalt chromium coronary stent alloy. Am. J. Cardiol. 92(4), 463–466 (2003).
  • Kastrati A, Mehilli J, Dirschinger J et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 103(23), 2816–2821 (2001).
  • Freitas JM, Zenteno M, Aburto-Murrieta Y et al. Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg. Neurol. 68(4), 378–386 (2007).
  • Kurre W, Berkefeld J, Sitzer M, Neumann-Haefelin T, du Mesnil de Rochemont R. Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology 50(8), 701–708 (2008).
  • Vajda Z, Miloslavski E, Güthe T et al. Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue): procedural safety, efficacy, and midterm patency. Neuroradiology 52(7), 645–651 (2010).
  • Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 36(12), e165–e168 (2005).
  • Gupta R, Al-Ali F, Thomas AJ et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 37(10), 2562–2566 (2006).
  • Qureshi AI, Kirmani JF, Hussein HM et al. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 59(5), 1044–1051; discussion 1051 (2006).
  • Miao ZR, Feng L, Li S et al. Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center. Neurosurgery 64(1), 79–84; discussion 84 (2009).
  • Vajda Z, Aguilar M, Göhringer T, Horváth-Rizea D, Bäzner H, Henkes H. Treatment of intracranial atherosclerotic disease with a balloon-expandable paclitaxel eluting stent: procedural safety, efficacy and mid-term patency. Clin. Neuroradiol. 22(3), 227–233 (2012).
  • Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110(7), 810–814 (2004).
  • Schachner T, Steger C, Heiss S et al. Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins. Eur. J. Cardiothorac. Surg. 32(6), 906–911 (2007).
  • Vajda Z, Güthe T, Perez MA et al. Prevention of intracranial in-stent restenoses: predilatation with a drug eluting balloon, followed by the deployment of a self-expanding stent. Cardiovasc. Intervent. Radiol. doi:10.1007/s00270-012-0450-9 (2012) (Epub ahead of print).
  • Scheller B, Hehrlein C, Bocksch W et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol. 97(10), 773–781 (2008).
  • Vajda Z, Güthe T, Perez MA et al. Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons. AJNR. Am. J. Neuroradiol. 32(10), 1942–1947 (2011).
  • Sundt TM Jr, Smith HC, Campbell JK, Vlietstra RE, Cucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin. Proc. 55(11), 673–680 (1980).
  • Feldman RL, Trigg L, Gaudier J, Galat J. Use of coronary Palmaz-Schatz stent in the percutaneous treatment of an intracranial carotid artery stenosis. Cathet. Cardiovasc. Diagn. 38(3), 316–319 (1996).
  • Henkes H, Bäzner H, Nelson PK. Comment on: stenting versus aggressive medical therapy for intracranial arterial stenosis. Clin. Neuroradiol. 21(4), 257–259 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.